-- 週三下午,醫療保健類股小幅上漲,紐約證券交易所醫療保健指數基本持平,回吐早盤漲幅,道富醫療保健精選行業SPDR ETF (XLV)上漲0.2%。 iShares生物科技ETF (IBB)上漲0.2%。 在公司新聞方面,波士頓科學公司 (BSX) 股價飆升9.1%,此前該公司公佈的第一季業績超出華爾街預期。 直覺外科公司 (ISRG) 股價上漲7.7%,此前該公司上調了其達文西機器人手術系統的全年手術量成長預期,並公佈了優於預期的第一季業績。 根據路透社報道,德國默克集團 (MRK) 和日本小野藥品工業株式會社 (Ono Pharmaceutical) 對Inhibrx Biosciences (INBX) 的實驗性抗癌藥物表示出興趣,該藥物的估值可能超過80億美元。默克股價上漲0.2%,Inhibrx股價飆漲42%。
Related Articles
Changhong's Attributable Profit Plummets 72% in Q1
Sichuan Changhong Electric's (SHA:600839) attributable profit fell 72% to 98.5 million yuan in the first quarter from 345.5 million yuan in the year-ago period, according to a Saturday filing with the Shanghai bourse.Earnings per share at the consumer electronics manufacturer decreased 71% to 0.0214 yuan from 0.0748 yuan in the prior-year period.Operating income edged up 1.6% year over year to 27.3 billion yuan from 26.8 billion yuan.Shares decreased 5% during morning trading on Monday.
China Energy Engineering Logs 29% Decrease in Q1 2026 Contract Value
China Energy Engineering (SHA:601868, HKG:3996) logged a 29% year-on-year decrease in total new contract value in the first quarter of 2026, according to a Hong Kong bourse filing Friday.Hong Kong-listed shares of the construction firm fell over 2% in Monday late morning trade.The value of new contracts reached 276.2 billion yuan during the quarter, including 184.81 billion yuan from domestic sources and 91.39 billion yuan from overseas.
Shanghai Zhangjiang Hi-Tech Park Development's Attributable Profit Slides 72% in Q1; Shares Fall 3%
Shanghai Zhangjiang Hi-Tech Park Development's (SHA:600895) attributable profit fell 72% to 83.5 million yuan in the first quarter from 294.5 million yuan in the year-ago period, according to a Saturday filing with the Shanghai bourse.Earnings per share at the real estate developer decreased 72% to 0.05 yuan from 0.18 yuan in the prior-year period.Operating income declined 31% year over year to 838 million yuan from 1.22 biliion yuan.Shares decreased 3% during the midday trade on Monday.